Drug ID: | NPD1483 |
Drug Name: | tricyclic broad-spectrum metallo-beta-lactamase inhibitors, SmithKline Beecham |
Molecular Formula: | C14H9NO6 |
Canonical SMILES: | Cc1ncc2c(c1)oc1c(c2=O)c(C(=O)O)c(c(c1)O)O |
Standard InCHI: | InChI=1S/C14H9NO6/c1-5-2-8-6(4-15-5)12(17)10-9(21-8)3-7(16)13(18)11(10)14(19)20/h2-4,16,18H,1H3,(H,19,20) |
Standard InCHIKey: | JQSDDXAUCUZICT-UHFFFAOYSA-N |
Max Developmental Stage: | Discontinued |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB001617 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 287.04 |
ALogP | -1.1388 |
MLogP | 2.23 |
XLogP | 1.327 |
HDA | 4 |
HBD | 3 |
Rotatable Bonds | 5 |
TPSA | 116.95 |
RO5 Violation | 0 |